SCHEMBL6786326

SCHEMBL6786326

Cn1ncc2nc3ccc(Cc4cccc(Cl)c4)cc3c(Cl)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.42
KDM4E B2RXH2 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C19 P33261 2/20 0.40
HIF1A Q16665 1/20 0.40
RORC P51449 3/20 0.39
ADCY10 Q96PN6 2/20 0.36
HTR6 P50406 2/20 0.36
MAOB P27338 1/20 0.36
LTA4H P09960 1/20 0.36
CCNC P24863 1/20 0.35
CDK8 P49336 1/20 0.35
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
IGF1R P08069 2/20 0.35
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
POLB P06746 1/20 0.34
HSP90AA1 P07900 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6786104 0.91 CYP3A4 (0.46) KDM4ECYP3A4CYP2C19HIF1ARORC
SCHEMBL6784794 0.89 CYP3A4 (0.46) PDE2AKDM4ECYP3A4CYP2C19HIF1A
SCHEMBL6786439 0.86 LTB4R (0.43) KDM4ECYP3A4CYP2C19HIF1AADCY10
SCHEMBL6784323 0.86 CYP3A4 (0.39) KDM4ECYP3A4CYP2C19HIF1ARORC
SCHEMBL6781436 0.85 DPP4 (0.45) KDM4ECYP3A4CYP2C19HIF1ARORC
SCHEMBL6781552 0.84 CYP3A4 (0.44) KDM4ECYP3A4CYP2C19HIF1ARORC
SCHEMBL6785057 0.84 CYP19A1 (0.42) KDM4EMEN1POLBMAPTHPGD
SCHEMBL6781849 0.82 PDE2A (0.38) PDE2AKDM4ECYP3A4CYP2C19HIF1A
SCHEMBL6785449 0.82 TUBB4A (0.46) KDM4ECYP3A4CYP2C19HIF1ARORC
SCHEMBL6786756 0.81 KDM4E (0.41) KDM4ECYP3A4CYP2C19HIF1ARORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed
EP-1310498-A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PFIZER INC. (US) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG PDE2A 2120/4885KDM4E 1349/4885CYP3A4 4093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.